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Abstract
The most common Rhodopsin (Rh) mutation associated with autosomal dominant retinitis pigmentosa (ADRP) in North
America is the substitution of proline 23 by histidine (Rh
P23H). Unlike the wild-type Rh, mutant Rh
P23H exhibits folding
defects and forms intracellular aggregates. The mechanisms responsible for the recognition and clearance of misfolded
Rh
P23H and their relevance to photoreceptor neuron (PN) degeneration are poorly understood. Folding-deficient membrane
proteins are subjected to Endoplasmic Reticulum (ER) quality control, and we have recently shown that Rh
P23H is a substrate
of the ER–associated degradation (ERAD) effector VCP/ter94, a chaperone that extracts misfolded proteins from the ER (a
process called retrotranslocation) and facilitates their proteasomal degradation. Here, we used Drosophila, in which Rh1
P37H
(the equivalent of mammalian Rh
P23H) is expressed in PNs, and found that the endogenous Rh1 is required for Rh1
P37H
toxicity. Genetic inactivation of VCP increased the levels of misfolded Rh1
P37H and further activated the Ire1/Xbp1 ER stress
pathway in the Rh1
P37H retina. Despite this, Rh1
P37H flies with decreased VCP function displayed a potent suppression of
retinal degeneration and blindness, indicating that VCP activity promotes neurodegeneration in the Rh1
P37H retina.
Pharmacological treatment of Rh1
P37H flies with the VCP/ERAD inhibitor Eeyarestatin I or with the proteasome inhibitor
MG132 also led to a strong suppression of retinal degeneration. Collectively, our findings raise the possibility that excessive
retrotranslocation and/or degradation of visual pigment is a primary cause of PN degeneration.
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Introduction
Collapse of protein homeostasis (proteostasis) due to protein
misfolding and aggregation is the central pathogenic event in
neurodegenerative disease [1]. Retinitis pigmentosa (RP) represents
a group of disorders characterized by progressive loss of
photoreceptor neurons (PNs) and blindness [2–4], and mutations
in the visual pigment Rhodopsin (Rh) are the most prevalent
genetic defects causing RP [5,6]. Rh is a G protein-coupled
receptor that initiates the phototransduction cascade and more
than 120 Rh point mutations have been associated with RP;
most of these Rh mutations act dominantly to cause autosomal
dominant RP (ADRP), while some mutations cause recessive RP
[7]. Based on their biochemical and cellular properties, Rh
mutations have been grouped into several classes [7]. Substitu-
tion of proline 23 by histidine (Rh
P23H)i st h em o s tc o m m o n
genetic defect associated with ADRP in North America and is
arguably the best characterized Rh mutation to date [3,7,8].
Unlike wild-type (WT) Rh, which is properly delivered to the
plasma membrane, mutant Rh
P23H fails to fold properly
[3,5,9,10], appears to exhibit enhanced retention within the
endoplasmic reticulum (ER) [3,5,7,11–13] and forms intracellu-
lar aggregates [14–16].
The presence of misfolded proteins in the ER activates the
unfolded protein response (UPR), an adaptive process which helps
reduce the load of unfolded proteins; chronic and excessive UPR
activation might be pro-apoptotic [17–19], although a moderate
increase in UPR activation (via the Ire1/Xbp1 pathway) is
protective for PNs [20]. In order to reduce protein misfolding-
induced stress within the ER, proteins with folding defects are
identified and cleared during a process called ER-associated
degradation (ERAD), which involves their export from the ER to
the cytosol (retrotranslocation) and degradation by the proteasome
[21,22]. The ATP-dependent chaperone Valosin-containing
protein VCP/ter94/p97/cdc48 is the driving force for the
retrotranslocation of misfolded proteins [23–25]. Two ATPase
domains (D1 and D2) generate the energy necessary for VCP to
promote extraction of misfolded substrates from the ER and
delivery to the proteasome [26,27]. Increased ERAD/VCP
activity leads to degradation of the cystic fibrosis-linked mutant
DF508-CFTR, which retains some functionality despite being
misfolded [28]. VCP also promotes degradation of the human V2
vasopressin receptor in X-linked nephrogenic diabetes insipidus
[29]. VCP co-localizes with aggregated Ataxin-3 [30], TDP-43
[31] or with ubiquitinated inclusions in Alzheimer’s and
Parkinson’s disease [32] suggesting that modulation of VCP
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(including neurodegenerative) disorders.
The mechanisms linking mutant Rh
P23H to PN degeneration in
ADRP are incompletely understood. Rh
P23H and other misfolded
Rh mutants were found to recruit the endogenous WT Rh into
aggregates (dominant-negative [DN] effect) leading to decreased
levels of mature WT Rh [15,33–36]. The mutant Rh
P23H might
acquire novel properties (gain-of-function [GOF] mechanism)
such as: aggregate formation or inclusion formation in the cytosol;
generation of ER stress and activation of the UPR pathways; other
toxic effects on diverse cellular processes [7,11,15,18,37]. There-
fore, a better understanding of the cellular and molecular
mechanisms mediating dominance in Rh
P23H-linked RP is required
for the development of effective therapies [7].
We have recently shown that misfolded Rh
P23H forms a
complex with the ERAD effector VCP in mammalian cell culture
systems. The interaction is maximal when both the N-terminal
and the D1 ATPase domains of VCP are present; furthermore,
VCP uses its D2 ATPase domain to promote Rh
P23H retro-
translocation and proteasomal delivery [16]. It remained unclear,
however, how the activity of VCP impacts on the Rh
P23H-mediated
retinal degeneration and blindness.
To address this question, we have used the previously
established Drosophila model of Rh
P23H-linked RP, in which
overexpression of Rh1
P37H (the equivalent of mammalian Rh
P23H)
in photoreceptor neurons leads to age- and light-dependent retinal
degeneration and blindness [11]. Here, we show that the
degeneration of PNs requires the presence of both mutant
Rh1
P37H and endogenous WT Rh1. Genetic inactivation of the
ERAD retrotranslocator VCP increased the levels of misfolded
Rh1
P37H but surprisingly, conferred protection against Rh1
P37H-
mediated retinal degeneration. Pharmacological inactivation of
VCP/ERAD or proteasome activities also led to a robust
suppression of Rh1
P37H-mediated neurodegeneration. Our results
suggest that excessive retrotranslocation and/or proteasomal
degradation of visual pigment is pathogenic for PNs.
Results
Proteostasis Defects and Retinal Degeneration in
Rh1
P37H-Expressing Flies
To understand how targeting and clearance of misfolded Rh
impact on the maintenance of PNs in RP, we used a previously
established Drosophila RP model, in which mutant Rh1
P37H (the
equivalent of mammalian Rh
P23H) is ectopically expressed in PNs
R1-6, under the control of a promoter identical to the endogenous
Rh1 promoter [11]. Flies overexpressing mutant Rh1
P37H (geno-
type: Rh1
P37H;Rh1
+/+), in contrast to flies overexpressing WT Rh1
(genotype: Rh1
WT;Rh1
+/+) and to control (Rh1-Gal4) flies display a
dramatic loss of PNs after 20 and 30 days of light exposure (dle)
(Figure 1A–1D). After 30 dle, ommatidia from Rh1
P37H;Rh1
+/+
retinas displayed 1.7 photoreceptors on average, compared to 5.5
in Rh1
WT;Rh1
+/+ and 6.5 in Rh1-Gal4 flies (n.7 eyes/genotype
and at least 150 ommatidia were analyzed/eye; ** p,0.01 and
*** p,0.001 student’s t-test). No degeneration was seen in
Rh1
P37H;Rh1
+/+ flies reared at light at postnatal day 1 (P1) or
reared in the dark at P30 (Figure S1). Thus, Rh1
P37H induces age-
and light-dependent retinal degeneration in Drosophila PNs.
In order to characterize the misfolded Rh1-induced proteostasis
defects in our transgenic flies, we collected fly heads of defined
genotypes and ages and following lysis in detergent-containing
RIPA modified buffer (see Materials and Methods), we separated
the lysates into detergent-soluble and insoluble fractions. We
expected most of the mature (rhabdomeric) Rh1 to be contained
within the detergent-soluble fractions, while aggregation-prone
Rh1 should be enriched in the detergent-insoluble fraction
[14,15]. To specifically detect the overexpressed protein, we used
flies in which ectopically expressed Rh1
P37H (or Rh1
WT) was hsv-
tagged [11,35]; in the following, all Rh1
P37H-hsv;Rh1
+/+ and Rh1
WT-hsv;
Rh1
+/+ flies are named Rh1
P37H;Rh1
+/+ and Rh1
WT;Rh1
+/+ respec-
tively, unless otherwise stated. When analyzing detergent-soluble
fractions, we found that 1-day-old Rh1
WT;Rh1
+/+ flies displayed
5567% more Rh1 than Rh1-Gal4 flies, both when reared in the dark
or at light (Figure S2A and Figure S3A and S3B) indicating that the
Rh1 promoter induces a moderate transgene expression (also seen by
[11]). Similar to Rh1
WT-expressing flies, 1-day-old Rh1
P37H;Rh1
+/+
flies displayed 5168% more Rh1 than Rh1-Gal4 flies when reared in
the dark (Figure S3B); interestingly, the same flies reared at light
displayed only 961% more Rh1 than Rh1-Gal4 flies (Figure S3A).
Moreover, light exposure (in contrastto dark rearing) led to loss of the
hsv signal in Rh1
P37H;Rh1
+/+but not Rh1
WT;Rh1
+/+flies(FigureS3C),
suggesting that light exposure exacerbates the Rh1
P37H maturation
defects. We also evaluated Rh1
P37H transgene expression on a Rh1
null background. Flies expressing one copy of the Rh1
P37H transgene
on a complete Rh1 null background (Rh1
P37H;Rh1
2/2), or two copies
of the mutant transgene on a complete Rh1 null background
(Rh1
P37H/Rh1
P37H;Rh1
2/2) had significantly higher levels of mature
Rh1
P37H when reared at light; Rh1 labeling revealed that Rh1
P37H/
Rh1
P37H;Rh1
2/2 flies (in which allRh1 is Rh1
P37H) exhibited levels of
mature Rh1
P37H that were comparable to those of the endogenous
Rh1 in Rh1
P37H;Rh1
+/+ flies (Figure S3D), reflecting the increased
dosage of the Rh1
P37H transgene. This suggests that the mutant
Rh1
P37H is able to traffic through the secretory pathway and this
p r o c e s si si m p a i r e db yl i g h te x p o s u r e .
We then performed a time-course analysis of Rh1 levels in our
transgenic and control flies exposed to light and found a dramatic
loss of mature Rh1 (endogenous and ectopic) in Rh1
P37H;Rh1
+/+
but not Rh1
WT;Rh1
+/+ flies after 20 dle (Figure 1E). We used an
hsv-specific antibody to label the ectopic protein and found a
complete loss of hsv signal in the Rh1
P37H;Rh1
+/+ soluble fraction
after 10 dle, while no loss of mature Rh1 occurred in Rh1
WT;Rh1
+/+
Author Summary
Patients affected by autosomal dominant retinitis pigmen-
tosa (ADRP) experience gradual loss of vision, and
mutations in the visual pigment Rhodopsin—a G pro-
tein-coupled receptor that mediates phototransduction—
are associated with ADRP. The most common ADRP
mutation is the substitution of proline 23 by histidine
(Rh
P23H), which causes Rh misfolding and aggregation. It is
currently unclear how mutant Rh
P23H leads to photore-
ceptor neuron (PN) degeneration in ADRP. We used the
fruitfly Drosophila melanogaster in which Rh1
P37H (the
equivalent of mammalian Rh
P23H) was overexpressed in
PNs. We found that the presence of both mutant Rh1
P37H
and endogenous Rh1 is required for neurodegeneration in
Rh1
P37H flies. To understand the impact of Rh1 misfolding
and clearance on PN degeneration, we inactivated the
chaperone VCP/ter94, which escorts misfolded proteins
out of the ER (a process termed retrotranslocation) and
delivers them for proteasomal degradation. Rh1
P37H flies
with decreased VCP function displayed more misfolded
Rh1
P37H but, remarkably, showed a potent suppression of
PN degeneration and blindness. Treatment of Rh1
P37H flies
with VCP or proteasome inhibitors also mitigated PN
degeneration. Our results suggest that excessive retro-
translocation and/or degradation of visual pigment is
deleterious for PN expressing misfolded Rh
P23H.
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Rh1
P37H maturation defects, and/or to excessive Rh1
P37H
degradation. We next assessed the situation of Rh1-containing
species in the detergent-insoluble fraction. We found a
significant increase in Rh1-containing oligomeric species that
migrated at approximately 250–300 kDa, in both Rh1
WT;Rh1
+/+
and Rh1
P37H;Rh1
+/+ flies after 20 dle (Figure 1F; whole WB
scans can be seen in Figure S4). These species represent small
Rh1 oligomers (probably containing 6–10 Rh1 molecules) that
were extracted using our detergent treatment protocol (and
supposedly found as such in vivo), although they might also have
assembled ex-vivo [14,38]. Control (Rh1-Gal4) retinas displayed
steady levels of mature Rh1 in the detergent-soluble fraction,
while some traces of oligomeric Rh1 were detected in the
detergent-insoluble fraction (Figure S2). Since Rh
P23H-containing
oligomeric species were previously found to be ubiquitinated
[14,36], we used an Ubiquitin-specific antibody to label Rh1-
containing oligomeric species in Drosophila, and found a robust
signal after 20 dle in Rh1
P37H;Rh1
+/+ flies (Figure 1F). This
suggests that Rh1-containing oligomers are ubiquitinated,
although it remains possible that other (Rh1-negative) species
are also Ubiquitin-positive. Remarkably, hsv labeling was absent
in the insoluble fraction from Rh1
P37H;Rh1
+/+, but not
Rh1
WT;Rh1
+/+ flies, raising the possibility that endogenous Rh1
is the major component of these Rh1 oligomeric species from
the Rh1
P37H retina (Figure 1F). It remains, however, possible
that the lack of hsv signal is due to epitope unavailability (due
to oligomerization) or that the hsv tag was cleaved. Accumu-
lation of endogenous Rh1 in the insoluble fraction from the
Rh1
P37H;Rh1
+/+ retina might be a consequence of WT Rh1
recruitment by the mutant Rh1
P37H [15,33–36]. To determine
whether the loss of mature Rh1 is the cause or the consequence
of retinal degeneration in Rh1
P37H;Rh1
+/+ flies, we compared the
time-dependent decrease in mature (rhabdomeric) Rh1 levels,
the decrease of the rhabdomeric marker TRP [39] levels and
the percentage of surviving PNs in the Rh1
P37H;Rh1
+/+ retina
(Figure 1G; results from 3 independent crosses were averaged).
As expected, death of PNs parallels the decrease in TRP levels,
consistent with the rhabdomeres being lost during retinal
degeneration; moreover, we found that no loss of mature Rh1
precedes the loss of PNs/TRP (Figure 1G). Therefore, the onset
of retinal degeneration in Rh1
P37H-expressing flies is not caused
by loss of mature Rh1; the reverse is true, i.e. loss of mature
Rh1 is the result of rhabdomere loss, which takes place during
Figure 1. Progressive retinal degeneration and Rh1 loss in Rh1
P37H-expressing flies exposed to light. (A–C) Photomicrographs of
toluidine blue stained semithin eye sections of Rh1-Gal4 (A), Rh1
WT;Rh1
+/+ (B) and Rh1
P37H;Rh1
+/+ (C) flies kept in light for 30 days. Dle: days of light
exposure. Scale bar is 50 mm. (D) Quantification of average number of photoreceptors/ommatidium (P/O) in different mutant groups (n.7 animals in
each group, **p,0.01 and *** p,0.001 t-test). Rh1
P37H;Rh1
+/+ flies display a dramatic loss of P/O after 20 dle. (E,F) Immunoblots revealing the
abundance of total (endogenous and ectopic, Rh1 antibody) and ectopic (hsv antibody) Rh1 in detergent-soluble (E) or insoluble (F) fractions
obtained from retinas of Rh1
WT;Rh1
+/+ or Rh1
P37H;Rh1
+/+ flies exposed to light for the indicated durations. The rhabdomeric marker TRP was used to
independently assess rhabdomere loss (E) while aggregates were independently labeled with an Ubiquitin antibody (F). b-Tubulin (b-Tub) served as
loading control. Please note that 5-fold less protein (E) was loaded for Rh1
WT;Rh1
+/+ flies for the hsv WB. (G) Graph describing the changes of mature
Rh1 levels (triangles), TRP levels (squares) and retinal degeneration (P/O; rhombus) in Rh1
WT;Rh1
+/+ and Rh1
P37H;Rh1
+/+ flies exposed to light for
increasing durations.
doi:10.1371/journal.pgen.1001075.g001
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rhabdomeric marker and found a similar profile to TRP (data
not shown). Furthermore, given the similar amounts of Rh1
oligomers in Rh1
WT;Rh1
+/+ and Rh1
P37H;Rh1
+/+ flies – despite
marked differences in retinal integrity – the formation of Rh1
oligomers is probably not a primary cause of retinal degener-
ation in Rh1
P37H;Rh1
+/+ flies.
The Endogenous Rh1 Is Required for Rh1
P37H Toxicity
The recruitment of endogenous Rh1 into insoluble aggregates
prompted us to investigate the relevance of endogenous Rh1 to the
retinal pathology initiated by Rh1
P37H. To reduce the dosage of
the endogenous Rh1 in Rh1
P37H;Rh1
+/+ flies, we used the Rh1 null
allele ninaE
I17 (here called Rh1
2). We found, remarkably, that PN
degeneration was strongly suppressed in Rh1
P37H;Rh1
+/2 flies
(Figure 2A–2C; n.7 eyes/genotype), suggesting that the endog-
enous Rh1 is required for Rh1
P37H toxicity. Consistent with the
rescue of PN degeneration, the levels of TRP and of total mature
Rh1, but not P37H ectopic Rh1 (hsv blot), were partially (5165%
and 5966,5% respectively) restored (Figure 2D), indicating that
rescue of retinal degeneration in Rh1
P37H;Rh1
+/2 flies correlated
with decreased degradation of endogenous Rh1. Interestingly,
increased dosage of the mutant Rh1
P37H transgene relative to
endogenous Rh1 led to an increased level of Rh1 oligomers in the
detergent-insoluble fraction (that contained a large fraction of
endogenous Rh1; Figure 2E, compare Rh1 and hsv blots) in
Rh1
P37H;Rh1
+/2 flies. We then wondered whether the mutant
Rh1
P37H is toxic by itself, i.e. if the presence of Rh1
P37H in PNs
completely deprived of endogenous Rh1 is sufficient to cause a
strong PN degeneration. For this, we generated Rh1
P37H;Rh1
2/2
flies (carrying one copy of the Rh1
P37H transgene on a Rh1 null
background) and Rh1
P37H/Rh1
P37H;Rh1
2/2 flies (carrying two
copies of the Rh1
P37H transgene on a Rh1 null background). As
mentioned above, Rh1
P37H maturation was significantly improved
in these mutants, (Figure S3D). When analyzing the retinal
integrity after 25 dle, we found, remarkably, that PN degeneration
was largely suppressed in Rh1
P37H;Rh1
2/2 and Rh1
P37H/
Rh1
P37H;Rh1
2/2 flies (Figure 2F–2I; n=7 eyes/genotype). Anal-
ysis of Rh1 levels at 25 dle also confirmed the rescue of retinal
degeneration (Figure S5). Therefore, the Rh1
P37H allele is not toxic
by itself, as it is insufficient to cause retinal degeneration when
expressed in the absence of the endogenous Rh1. Retinal
degeneration in Rh1
P37H;Rh1
+/+ flies therefore depends on a
cellular environment containing both misfolded Rh1
P37H and
endogenous WT Rh1.
VCP Is Required In Vivo for Clearance of Misfolded
Rh1
P37H
To investigate the relevance of Rh1
P37H retrotranslocation and
clearance to retinal degeneration, we focused our attention on the
ERAD effector VCP/ter94/p97/cdc48, the driving force for
extraction of misfolded proteins from the ER and delivery to the
proteasome [23,24,27]. To test whether VCP activity is required
for clearance of misfolded Rh1, we reduced VCP function using
the hypomorphic allele ter94
26-8 [40] that we refer to as VCP
26-8
(Figure S6A). Using Rh1- and Ubiquitin-specific antibodies to
label oligomeric species, we found that Rh1
P37H;VCP
26-8/+;Rh1
+/+
flies, in contrast to Rh1
P37H;Rh1
+/+ and control flies, displayed a
strong increase in total levels of oligomeric Rh1 at 10 dle
(Figure 3A) and similarly at 20 (Figure S6B) and 30 dle (Figure 3B).
Flies carrying the VCP
26-8 allele in an otherwise WT background
(genotype: VCP
26-8/+;Rh1
+/+) also displayed slightly more oligo-
meric Rh1 relative to control flies (Figure 3A and 3B) suggesting
that VCP is involved in the quality control of endogenous Rh1,
which might be a client of ERAD under physiological conditions
[41]. When using hsv antibody to label the ectopic Rh1
P37H,w e
found an increased signal in the Rh1
P37H;VCP
26-8/+;Rh1
+/+ retina
as compared to the Rh1
P37H;Rh1
+/+ retina (Figure 3C and 3D and
Figure S6C). Thus, partial VCP inactivation prevents the loss of
misfolded Rh1
P37H. Importantly, this finding also indicates that we
are able to detect oligomeric species containing the mutant
Rh1
P37H. Therefore, the absence of Rh1
P37H from the insoluble
fractions of Rh1
P37H;Rh1
+/+ flies (Figure 1F) suggests that the
mutant Rh1
P37H was degraded, in a process that required VCP
activity. Since the increase in Rh1-containing oligomeric species
was observed before the onset of retinal degeneration (at 10 dle),
we can rule out that this effect was indirectly caused by differences
in retinal integrity. Thus, VCP activity is required in vivo for
degradation of misfolded Rh1
P37H.
To determine the levels of mature (soluble) Rh1 in retinas derived
from Rh1
P37H;VCP
26-8/+;Rh1
+/+, Rh1
P37H;Rh1
+/+ or control flies, we
used detergent-soluble fractions and a Rh1-specific antibody to
reveal their content of mature Rh1. While the levels of mature total
(endogenous and ectopic) Rh1 were similar for all groups after 10
dle (Figure 3E), we found a dramatic loss of mature Rh1 in
Rh1
P37H;Rh1
+/+ flies after 20 dle (Figure S6D) and 30 dle (Figure 3F
and 3I; see also Figure 1E). Remarkably, partial VCP inactivation
led to an almost complete rescue of mature Rh1 levels (Figure 3F
and 3I; results from 3 independent crosses were averaged) and
similarly, restored the levels of the rhabdomeric marker TRP
(Figure 3F and 3J), suggesting decreased retinal degeneration in the
Rh1
P37H;VCP
26-8/+;Rh1
+/+ retina after 30 dle. We observed a
similar, although moderate, rescue of the mature ectopic Rh1
P37H
(hsv-labeled) after 20 dle (Figure S6E) and 30 dle (Figure 3H), but
also after 10 dle (Figure 3G) and 1 dle (data not shown). The
increased levels of mature Rh1
P37H in the intact (1–10 dle)
Rh1
P37H;VCP
26-8/+;Rh1
+/+ retina suggests that partial VCP inactiva-
tion not only prevents Rh1
P37H degradation but also allows some of
the mutant Rh1
P37H to traffic through the secretory pathway.
Increased Ire1/Xbp1 Pathway Activation in Rh1
P37H-
Expressing Flies with Decreased VCP Function
Accumulation of misfolded proteins in the ER activates the
UPR; the unconventional splicing of xbp1 mRNA is favored during
the UPR, generating a transcription factor that activates stress
response genes, including the ER stress sensor and chaperone
Hsc3/BiP [37,42,43]. We tested for the occurrence of xbp1 mRNA
unconventional splicing by inducing ubiquitous expression of an
UAS-xbp1-EGFP construct, which activates EGFP expression only
after unconventional splicing [37]. We stained retinas using a
GFP-specific antibody [20,37] and determined the density of GFP-
positive profiles for the different genotypes. We found that Xbp1-
EGFP activation is increased in Rh1
P37H;Rh1
+/+ retinas relative to
Rh1
WT;Rh1
+/+ and control retinas (Figure 4A–4C and 4G).
Rh1
P37H;Rh1
+/+ flies carrying VCP
26-8, Rh1
2 or the stronger VCP
loss-of -function (LOF) allele VCP
k15502 [40] displayed an
increased density of GFP positive profiles in the retina
(Figure 4D–4G; n.5 eyes/genotype), consistent with them having
increased levels of misfolded oligomeric Rh1 (see Figure 2E and
Figure 3A–3D). We then determined the levels of the Hsc3/BiP
chaperone in the retina, as an independent read-out for ER stress
[18,20,37]. Using a Hsc3-specific antibody [37], we found that
Rh1
P37H;Rh1
+/+retinas display a 50% increase in Hsc3 levels
relative to Rh1
WT;Rh1
+/+ retinas, starting from P1 (Figure S6F and
S6G). Moreover, as previously seen for Xbp1-EGFP activation,
Rh1
P37H;Rh1
+/+ flies carrying VCP
26-8, Rh1
2 or VCP
k15502 alleles
displayed increased Hsc3 levels compared to control flies and to
Rh1
P37H;Rh1
+/+ carrying WT alleles of VCP or Rh1 (Figure 4H and
VCP Inactivation Mitigates Rhodopsin Pathology
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averaged). Therefore, the increased levels of misfolded Rh1 seen
after partial removal of VCP or endogenous Rh1 function were
associated with increased activation of the Ire1/Xbp1 UPR
pathway.
Suppression of Rh1
P37H-Induced Retinal Degeneration by
VCP Loss-of-Function Alleles
We next investigated the effect of decreasing VCP function on
Rh1
P37H-induced PN degeneration. We found that Rh1
P37H;Rh1
+/+
and Rh1
P37H;VCP
26-8/+;Rh1
+/+ retinas showed a similar degree of
Figure 2. The endogenous Rh1 is required for Rh1
P37H toxicity. (A–C,F–I) Reducing the dosage of endogenous Rh1 rescues retinal
degeneration in Rh1
P37H;Rh1
+/+ flies, suggesting that endogenous Rh1 is required for Rh1
P37H toxicity. Photomicrographs of toluidine blue sections of
Rh1
P37H;Rh1
+/+ (A,F), Rh1
P37H;Rh1
+/2(B), Rh1
P37H;Rh1
2/2 (G) and Rh1
P37H/Rh1
P37H;Rh1
2/2 (H) flies at 20 dle (A,B) and 25 dle (F–H) and (C,I) quantification
of the average number of P/O (n.7 animals/group, * p,0.05 and *** p,0.001 t-test). Scale bar is 50 mm. (D,E) Immunoblots showing the levels of
total and ectopic mature (D) and aggregated Rh1 (E), as well as TRP levels in flies of indicated genotypes, after 20 dle. b-Tubulin (b-Tub) served as
loading control. Overexpressed WT or P37H Rh1 was hsv-tagged and Rh1-Gal4 flies, lacking hsv, served as negative control for the hsv antibody
Please note that 10-fold less protein (D) was loaded for Rh1
WT;Rh1
+/+ flies for the hsv WB.
doi:10.1371/journal.pgen.1001075.g002
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PLoS Genetics | www.plosgenetics.org 6 August 2010 | Volume 6 | Issue 8 | e1001075Figure 4. Decreasing VCP function increases the activation of the Ire1/Xbp1 UPR pathway in Rh1
P37H-expressing flies. (A–F) Horizontal
retinal cryosections from flies after 10 days of light exposure (dle) were stained with an anti-GFP antibody. xbp1-EGFP is expressed under the control
of actin promoter. Unconventional xbp1 mRNA splicing is increased in the Rh1
P37H;Rh1
+/+ (C) retina while further removal of VCP (D,E) or endogenous
Rh1 function (F) strongly enhances xbp1 unconventional splicing, revealed by EGFP expression. Scale bar is 75 mm and inset is 10 mm. (G)
Quantification of Xbp1-EGFP positive nuclei. Results are expressed as number of EGFP-positive nuclei per area from five different flies/group
(** p,0.01 t-test). (H) Immunoblot showing the levels of Hsc3 and TRP in flies of indicated genotypes after 10 dle. Rh1
P37H;Rh1
+/+ retinas exhibit more
Hsc3 compared to control and Rh1
WT;Rh1
+/+ retinas, while further removal of VCP or endogenous Rh1 function leads to a further increase in Hsc3
levels. b-Tubulin (b-Tub) served as loading control. (I) Quantification of Hsc3 levels (normalized to TRP levels) was averaged from three independent
experiments (* p,0.05 t-test).
doi:10.1371/journal.pgen.1001075.g004
Figure 3. Decreasing VCP function increases Rh1 aggregate load and restores mature Rh1 levels in Rh1
P37H-expressing flies. (A–D)
Immunoblots showing the levels of total (A,B, endogenous and ectopic, Rh1 antibody) and ectopic (C,D, hsv antibody) Rh1 aggregates in flies of
indicated genotypes after 10 (dle) (A,C) or 30 (B,D) days of light exposure (dle). An Ubiquitin-specific antibody was used to independently label
aggregates. Rh1
P37H;VCP
26-8/+;Rh1
+/+ flies display increased aggregate levels compared to the other mutant flies. (E–H) Immunoblots revealing the levels
of total (E,F, endogenous and ectopic, Rh1 antibody) and ectopic (G,H, hsv antibody) mature Rh1, as well as TRP levels in flies of indicated genotypes
after 10 dle (E,G) and 30 (F,H) dle. Loss of endogenous and ectopic mature Rh1 in Rh1
P37H;Rh1
+/+ flies is rescued in Rh1
P37H;VCP
26-8/+;Rh1
+/+ flies.
Overexpressed WT or P37H Rh1 was hsv-tagged and Rh1-Gal4 flies, lacking hsv, served as negative control for the hsv antibody. Note that 10-fold less
protein was loaded for the Rh1
WT;Rh1
+/+ flies (G,H) and b-Tubulin (b-Tub) served as loading control. (I,J) Quantifications of Rh1 levels (I) and of TRP levels
(J) in flies of indicated genotypes, after 30 dle. Values from three independent experiments were averaged (**p,0.01 and *** p,0.001 t-test).
doi:10.1371/journal.pgen.1001075.g003
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degeneration (at P30) in the Rh1
P37H;Rh1
+/+ retina was prevented
in the VCP
26-8 background (Figure 5D, 5E, and 5G). Remarkably,
PN degeneration was strongly suppressed in Rh1
P37H;Rh1
+/+ flies
carrying the stronger VCP LOF allele VCP
k15502 (genotype:
Rh1
P37H;VCP
k15502/+;Rh1
+/+), both at P20 and P30 (Figure 5A,
5C, 5D, 5F, and 5G). Thus, VCP inactivation exerts a protective
role on Rh1
P37H-mediated retinal degeneration. We then used a
VCP-specific antibody to assess the levels of VCP in
Rh1
P37H;Rh1
+/+ versus Rh1
WT;Rh1
+/+ flies. We found a small (2-
fold) but consistent increase in VCP levels in Rh1
P37H;Rh1
+/+ flies
at P1, which was not maintained at P10 (Figure 5H and 5I; results
from 3 independent crosses were averaged). Although an initial
increase in VCP levels might induce long-term cellular changes
that contribute to PN degeneration, and changes in VCP
activation status or localization might be pro-apoptotic, our results
suggest that differences in VCP levels play a minor, if any, direct
pro-apoptotic role in Rh1
P37H-mediated retinal degeneration.
Pharmacological Inhibition of the VCP/ERAD/Proteasome
Axis Suppresses Retinal Degeneration in Rh1
P37H-
Expressing Flies
Our finding that VCP inhibition rescues retinal degeneration in
Rh1
P37H;Rh1
+/+ flies suggests that inhibition of the ERAD activity
might exert long-term protective effects in Rh1
P37H PNs. The tight
coupling between VCP and proteasome activities is essential for
substrate delivery and clearance during ERAD [23] and
interestingly, proteasome activity is required for proper substrate
retrotranslocation [15]. To independently test whether inhibition
of the VCP/ERAD/proteasome axis is protective for Rh1
P37H-
expressing PNs, we used the VCP/ERAD inhibitor Eeyarestatin I
(EerI) and the proteasome inhibitor MG132 that we dissolved in
fly food. EerI acts on deubiquitinating enzymes that function
downstream of VCP during ERAD and therefore inhibits ERAD-
associated VCP functions [44,45]. MG132 is a classical protea-
some inhibitor and potently inhibits the proteasome in Drosophila
S2 cells [46,47]. We measured the proteasome activity on head
extracts (see Text S1) from control flies to which MG132 was
added after lysis and determined that MG132 potently inhibits the
activity of the proteasome (Figure S7).
Using two doses of EerI (1 mM and 10 mM), we found that
partial VCP/ERAD inhibition potently suppressed retinal degen-
eration in Rh1
P37H;Rh1
+/+ flies after 30 dle (Figure 6B–6D and 6G;
n.7 flies/genotype). Both doses displayed the same (partial)
suppression of PN degeneration, suggesting that a higher dose is
required to achieve a more complete rescue or that EerI only
inhibits some, but not all, ERAD-related VCP functions.
Rh1
P37H;Rh1
+/+ flies transferred to food containing 5 mM
Figure 5. Suppression of Rh1
P37H-induced retinal degeneration by VCP loss-of-function alleles. (A–F) Photomicrographs of toluidine blue-
stained semithin eye sections of Rh1
P37H;Rh1
+/+ (A,D), Rh1
P37H;VCP
26-8/+;Rh1
+/+ (B,E) and Rh1
P37H;VCP
k15502/+;Rh1
+/+ (C,F) flies after 20 (A–C) or 30 (D–F)
days of light exposure (dle). Scale bar is 50 mm. (G) Quantification of average number of photoreceptors/ommatidium (P/O) (n.7 animals/group,
*p ,0.05, ** p,0.01 and *** p,0.001 t-test). Decreasing VCP function potently suppresses retinal degeneration caused by Rh1
P37H. (H) Immunoblot
revealing the levels of VCP in Rh1
WT;Rh1
+/+ and Rh1
P37H;Rh1
+/+ retinas, exposed to light for increasing durations. Rh1
P37H;Rh1
+/+ display a 2.25-fold
increase of VCP levels relative to Rh1
WT;Rh1
+/+ retinas after 1 dle. b-Tubulin (b-Tub) served as loading control. (I) Quantification of VCP expression
levels revealed higher VCP levels in Rh1
P37H;Rh1
+/+ flies after 1 dle. VCP levels were averaged from three independent experiments (** p,0.01 t-test).
doi:10.1371/journal.pgen.1001075.g005
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degeneration after 30 dle (Figure 6B, 6E, and 6G). Remarkably,
treatment of Rh1
P37H;Rh1
+/+ flies with 50 mM MG132 led to a
very dramatic rescue of retinal degeneration, the average number
of photoreceptors/ommatidium reaching 5.5 (Figure 6B, 6F, and
6G; n.7 flies/genotype and .150 ommatidia scored/animal).
Taken together, these results indicate that inhibition of the VCP/
ERAD/proteasome axis is protective for Rh1
P37H-expressing PNs,
further suggesting that excessive retrotranslocation and/or degra-
dation of visual pigment is a critical pro-apoptotic event in the
Rh1
P37H retina.
Partial VCP Inactivation Restores Visual Processing in
Rh1
P37H-Expressing Flies
The almost complete restoration of mature Rh1 levels in
Rh1
P37H;VCP
26-8/+;Rh1
+/+ flies prompted us to investigate visual
processing in these flies. To assess the capacity of different mutants
to process visual information, we performed fast phototaxis
measurements [11,48,49]. This analysis reflects the average visual
functioning of a fly population and scores the percentage of flies
that successfully respond to five consecutive light stimulations.
Control flies are normally attracted by light, and the analysis of
light responses in different groups of mutants serves as an indicator
of their retinal integrity. After 20 dle, we found that Rh1
WT;Rh1
+/+,
Rh1
WT;VCP
26-8/+;Rh1
+/+ and VCP
26-8/+;Rh1
+/+ flies displayed a
normal and highly reproducible response to light, i.e. most of these
flies moved towards the light source (positive phototaxis) in all five
consecutive light stimulations (Figure 7A; n=277–451 flies/
genotype). In contrast, Rh1
P37H;Rh1
+/+ flies were seriously
impaired in their light processing capability (Figure 7A) and had
a significantly lower phototactic score (PS, defined in Materials
and Methods) as compared to Rh1
WT;Rh1
+/+ and control flies
(Figure 7B) [11]. Remarkably, in Rh1
P37H;VCP
26-8/+;Rh1
+/+ flies,
positive phototaxis was dramatically improved, consistent with
these flies having normal levels of mature Rh1 (Figure 7A and 7B;
see Figure S6D). We obtained similar results after 30 dle (Figure 7C
and 7D). To rule out that other non-visual related impairments
account for the performance of Rh1
P37H;Rh1
+/+ flies in the
phototaxis test, we used geotaxis to measure motor functioning
in these and all other fly groups, and found that all had a similar
motor ability after 20 and 30 dle (Figure 7E and 7F). We found a
similar rescue of visual processing in Rh1
P37H-expressing flies when
carrying the stronger LOF allele, VCP
k15502 (Figure S8H, S8I, S8J);
moreover, Rh1
P37H-expressing flies carrying one Rh1 null allele
(Rh1
2) also showed improved phototaxis (Figure S8K, S8L, S8M)
although the recovery was partial, reflecting their Rh1 content
(Figure 2D). To evaluate whether the protective effect achieved by
partial VCP inhibition also extends to other class II Rh1 mutations,
we used another class II mutant, ninaE
D1 (Rh1
S137F), which also
displays a progressive decline in visual acuity [34]. We found,
similarly, that reducing VCP activity partially suppressed the loss of
PNs in the ninaE
D1/+ retina (Figure S8A, S8B, S8C, S8D) and
restored the vision deficits displayed by the ninaE
D1/+ flies (Figure
S8E, S8F, S8G). Thus, reducing VCP activity rescues retinal
degeneration and blindness induced by a second class II mutant,
ninaE
D1.
Finally, to obtain more direct evidence for a functional rescue of
visual processing in Rh1
P37H;VCP
26-8/+;Rh1
+/+ PNs, we performed
Figure 6. Rescue of Rh1
P37H-induced retinal degeneration after inhibiting the VCP/ERAD (EerI) or the proteasome (MG132) activity.
(A–F) Photomicrographs of toluidine blue-stained semithin eye sections of Rh1
WT;Rh1
+/+ flies fed on control food (A); Rh1
P37H;Rh1
+/+ flies fed on
control food (B); Rh1
P37H;Rh1
+/+ flies fed on food containing 1 mM (C), or 10 mM (D) EerI; Rh1
P37H;Rh1
+/+ flies fed on food containing 5 mM (E) or 50 mM
(F) MG132 after 30 dle. Dle: days of light exposure. Scale bar is 50 mm. (G) Quantification of average number of photoreceptors/ommatidium (P/O)
(n.7 animals/group, ** p,0.01 and *** p,0.001 t-test).
doi:10.1371/journal.pgen.1001075.g006
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mined that, in contrast to Rh1-Gal4, Rh1
WT;Rh1
+/+, VCP
26-8/+;
Rh1
+/+ or Rh1
WT;VCP
26-8/+;Rh1
+/+ retinas, which displayed a
normal photoreceptor depolarization following light stimulation,
Rh1
P37H-expressing photoreceptors had a decreased amplitude of
photoreceptor depolarization (plateau), both after 30 and 45 dle,
consistent with their retinal degeneration phenotype (Figure 8;
n=12–20 flies/genotype). In contrast, light processing in
Rh1
P37H;VCP
26-8/+;Rh1
+/+ photoreceptors was largely rescued,
the ERG amplitude values for these flies reaching control levels,
both after 30 dle (Figure 8A and 8B) and after 45 dle (Figure 8C
and 8D). Taken together, the deleterious effects of mutant Rh1
P37H
on light transduction and photoreceptor depolarization are almost
completely suppressed by inactivating the function of the ERAD
effector VCP, indicating that VCP activity promotes neurodegen-
eration in the Rh1
P37H retina.
Discussion
In our recent study [16] we found that the ERAD effector VCP
interacts with misfolded Rh
P23H in mammalian cells and promotes
its ATP-dependent retrotranslocation and proteasomal clearance.
Here, we have used Drosophila transgenics in which Rh1
P37H (the
equivalent of mammalian Rh
P23H) induces progressive light- and
Figure 7. Altered phototaxis in Rh1
P37H-expressing flies is rescued by VCP loss-of-function allele. (A,C) Phototaxis histograms after 20 (A)
or 30 (C) days of light exposure (dle) revealing the light response of flies of indicated genotypes. (B,D) Phototactic score (PS) after 20 (B) or 30 (D) dle
reveals impairment of light response in Rh1
P37H;Rh1
+/+ flies and rescue after decreasing VCP function (n=277–451 flies/genotype, in 3 independent
experiments, *** p,0.001 t-test). (E,F) No differences in motor performance in mutant versus control flies chronically exposed to light. Geotactic score
of flies of indicated genotypes after 20 (E) or 30 (F) dle. Flies from all genotypes display similar geotactic scores after 20 and 30 dle.
doi:10.1371/journal.pgen.1001075.g007
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the levels of the endogenous Rh1, as well as the activity of VCP.
We found that misfolded Rh1
P37H induces deleterious effects in
PNs only in the presence of its WT endogenous counterpart.
These deleterious effects include an excessive retrotranslocation
and/or degradation of Rh1, mediated by VCP. We suggest that
the VCP/ERAD/proteasome axis is a component of Rh1
P37H-
induced toxicity in PNs.
Proteostasis Defects in the Rh1
P37H Retina
As a first step toward a detailed characterization of Rh1
P37H
proteostasis defects and their relevance to PN integrity, we
evaluated the detergent solubility of Rh1 species extracted from
transgenic Rh1
P37H;Rh1
+/+ and Rh1
WT;Rh1
+/+ retinas. In deter-
gent-soluble fractions, we observed an early depletion of the
misfolded Rh1
P37H (already after 1 dle), which suggests maturation
defects. These maturation defects were only seen at light (Figure
S3C) and were alleviated after partial VCP inactivation (Figure 3G),
suggesting that light-stimulated visual activity might impact on the
maturation of Rh1
P37H by promoting VCP-mediated ERAD of
Rh1
P37H.
The detergent-insoluble fractions from transgenic retinas were
enriched in Rh1 oligomeric species that migrated at approximately
250–300 kDa - thus presumably containing 6–10 Rh1 molecules.
After 20 dle, Rh1
P37H and Rh1
WT-expressing flies displayed high
levels of Rh1 oligomers, and oligomer traces were also detected in
control (Rh1-Gal4) flies; this might be potentially due to reduced
folding capacity of the ER during aging (that can be further
impaired by protein overexpression or misfolding). Since VCP
inactivation (which suppressed degeneration) also increased the
levels of Rh1 oligomers and both Rh1
WT and Rh1
P37H-expressing
flies (at P20-P30) displayed high levels of oligomers (despite clear
differences in retinal integrity), the presence of these Rh1
oligomers is probably not the cause of retinal degeneration in
the Rh1
P37H;Rh1
+/+ retina. We found a complete absence of
mutant Rh1
P37H from Rh1-containing oligomers in Rh1
P37H flies,
Figure 8. Blindness in Rh1
P37H-expressing flies is rescued in a VCP hypomorphic background. (A,C) ERG after 30 (A) or 45 (C) days of light
exposure (dle). Plateau represents photoreceptor depolarization. Rh1
P37H;Rh1
+/+ flies (red tracing) display reduced plateau amplitude, while partial
VCP inactivation restores their light transduction almost to control levels. Time scale: 1 second and plateau amplitude scale: 5 mV. (B,D) Average
depolarization amplitudes after 30 (B) or 45 (D) dle. Impaired light transduction in Rh1
P37H;Rh1
+/+ flies is rescued in a VCP
26-8 background (n=12–20
flies/group, * p,0.05 and ** p,0.01 t-test).
doi:10.1371/journal.pgen.1001075.g008
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P37H-containing
oligomers (Figure 3C and 3D and Figure S6C). The fact that we
detected Rh1
P37H oligomers (hsv positive; Figure 3C and 3D) in
Rh1
P37H;VCP
26-8/+;Rh1
+/+ retina suggests that the absence of
Rh1
P37H from Rh1 oligomeric species in the Rh1
P37H;Rh1
+/+
retina is due to Rh1
P37H degradation, and not to failure to detect
the hsv tag. The increased levels of hsv-labeled Rh1
P37H oligomers
in the insoluble fraction from the Rh1
P37H;VCP
26-8/+;Rh1
+/+ retina
and the activation of the Ire1/Xbp1 ER stress pathway under
these conditions (suggesting that these species accumulated in the
ER; Figure 4) suggest that VCP activity promotes degradation of
Rh1
P37H, probably by mediating its retrotranslocation from the
ER into the cytosol [16,24,27]. However, VCP might also
promote autophagic degradation of proteins [51–53] and it
remains to be determined whether Rh1
P37H is also degraded by
autophagy and whether VCP is involved in this process.
Our experimental protocol for extraction and detection of Rh1-
containing insoluble species might not allow us to infer the true
nature of Rh1-containing insoluble species in vivo. First, the
detergent used during extraction might perturb higher-order
aggregates (e.g. protofibrils, fibrils) causing them to disassemble
during extraction; in addition, different detergents can lead to the
extraction of different Rh oligomeric species [54,55]. Second, Rh1
is able to form oligomers ex vivo, during sample preparation. Third,
insoluble higher-order aggregates might not enter the SDS-PAGE
gel, and remain undetected. Another limitation of our biochemical
approach is the lack of information concerning the subcellular
localization of Rh1-containing oligomers or aggregates. Further
studies using different extraction protocols and/or more powerful
biophysical approaches (e.g. spectroscopy using fluorescent probes,
fluorescence resonance energy transfer, atomic force microscopy
[54,56]) but also the development of antibodies highly specific to
various Rh1 epitopes [57] might help to precisely determine the
composition and subcellular localization of Rh1-containing species
in the diseased retina.
Endogenous Rh1 Is Required for Rh1
P37H Toxicity
We found that PN degeneration in the Rh1
P37H;Rh1
+/+ requires
an environment in which both mutant Rh1
P37H and endogenous
Rh1 are present. Thus, the Rh1
P37H-mediated neurodegeneration
was strongly suppressed in Rh1 null background, suggesting that
the Rh1
P37H allele is not toxic by itself nor is it sufficient to cause
cell death in the absence of its WT counterpart. Transgenic
Rh1
WT;Rh1
+/+ flies displayed minor degenerative signs in the
retina, suggesting that WT Rh1 alone is not sufficient to cause
degeneration. Similar conclusions were also reached with another
class II Rh1 mutant, ninaE
D1 [34].
Experiments performed in transgenic mice overexpressing a
triple (P23H, V20G, P27L) Rh mutant (Rh
GHL) indicated that
decreased levels of endogenous Rh accelerated the rate of retinal
degeneration [58]. These findings are in apparent conflict with our
present observations and with those made using ninaE
D1 flies [34].
Both Rh
GHL mice and Rh1
P37H flies express the mutant Rh at
moderate levels (10–25% and 51% of normal levels, respectively),
suggesting that toxicity was not due to overexpression. Several
differences between the two models might explain these findings.
First, Rh
GHL is a triple Rh mutant and might display different
properties when compared to Rh
P23H; the analysis of Rh
P23H
transgenic mice [59] will address this possibility. Second, the
subcellular localization of the mutant Rh was different, Rh
GHL
being properly targeted to the membrane (in the Rh
GHL;Rh
+/+
retina), while Rh1
P37H showed severe maturation defects
(Rh1
P37H;Rh1
+/+ retina). Interestingly, removal of endogenous Rh
function impacted (in opposite ways) on the maturation of
misfolded Rh, and Rh maturation defects caused a more severe
pathology in both cases. It would be thus interesting to evaluate
the effect of VCP heterozygosity in the Rh
GHL retina. Third, the
most notable difference is that Rh
GHL-mediated degeneration does
not require exposure to light (but can be further accelerated by
light [8,60,61]), while the Rh1
P37H-induced degeneration is strictly
light-dependent. Interestingly, we also found that light exposure
impairs the maturation of Rh1
P37H, suggesting a possible
interaction between visual processing and the protein quality
control machinery in controlling Rh1 homeostasis. Future studies
examining Rh
P23H RP patients will establish the role played by
light in RP.
VCP Activity Promotes Retinal Degeneration and
Blindness in the Rh1
P37H Retina
Partial VCP inactivation rescued retinal degeneration and
blindness in Rh1
P37H flies; moreover, the rescuing effect of VCP
inactivation also extends to another class II Rh1 mutation, ninaE
D1
(Figure S8). Two lines of evidence suggest that the effect of VCP
on the Rh1
P37H pathology involves its activity as ERAD effector.
First, the levels of VCP were found to be increased very early (after
1dle) in Rh1
P37H-expressing flies, well before the onset of retinal
degeneration; this suggests that VCP has no direct cell death-
promoting activity. Since UPR activation might induce ERAD
genes [19], the increase in VCP levels might have been caused by
the early activation of the Ire1/Xbp1 pathway. Second, our
pharmacological treatment with the EerI inhibitor potently
suppressed retinal degeneration in Rh1
P37H flies. EerI was reported
to inhibit the activity of deubiquitinating enzymes acting
downstream of VCP during ERAD, therefore inhibiting an
ERAD-associated VCP activity [44,45]. Our pharmacological
treatment with the proteasome inhibitor MG132 also led to a
dramatic suppression of retinal degeneration in the Rh1
P37H retina
and the proteasome was shown to be tightly coupled to substrate
retrotranslocation during ERAD [15,62,63]. The very potent
rescuing effect on PN degeneration after genetic inactivation of
VCP, or after pharmacological treatment with EerI or MG132
suggests that excessive retrotranslocation and/or degradation of
visual pigment is pathogenic for Rh1
P37H PNs.
Our results suggest that mechanism underlying Rh1
P37H
dominance in the retina is not a DN effect on the maturation of
WT Rh1; the endogenous Rh1 matured normally in Rh1
P37H flies
(see also [11]) and no decrease in the levels of mature Rh1
preceded PN degeneration in Rh1
P37H flies (Figure 1G). Excessive
VCP-mediated degradation of visual pigment might be an
underlying mechanism of Rh1
P37H dominance in PNs. The
Rh1
P37H mutant is not toxic by itself (Figure 2) but requires the
endogenous Rh1, VCP activity and light exposure to cause
massive PN degeneration. All components of this quadruple
interaction network are necessary for toxicity, as elimination of
any of them mitigates neurodegeneration. How do these network
components relate to each other? The hypothesis we favor is that
light-initiated visual processing affects the maturation and stability
of the mutant Rh1
P37H, leading to its enhanced VCP-dependent
degradation, with deleterious consequences for the cell. During
visual processing, the rhabdomeric WT Rh1 undergoes repeated
cycles of internalization [64] and new Rh1 synthesis might re-
supply the rhabdomeres. The synthesis and trafficking of WT Rh1
through the ER might be enhanced following light exposure, and
this might saturate the ER folding machinery. Excess WT Rh1
might fail to fold, and could self-assemble (to form oligomers, as
seen in Figure 1F). At the same time, misfolded Rh1
P37H would
undergo ERAD at a higher rate, which might be pathogenic. The
competition between WT Rh1 and Rh1
P37H for the ER folding
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to determine how light exposure and dark rearing impact on the
activity of ERAD, in the presence of WT and/or P37H Rh1.
How do enhanced retrotranslocation and/or degradation of
visual pigment lead to PN degeneration in the Rh1
P37H retina?
Excessive retrotranslocation might activate pro-apoptotic path-
ways, under conditions of chronic ERAD activity. Excessive
Rh1
P37H retrotranslocation might also increase the amount of
cytosolic Rh1
P37H, which might aggregate if left undegraded.
Cytosolic Rh1
P37H-containing aggregates might be more toxic
than Rh1
P37H mono/oligomers located in the ER and might
generate yet unidentified pro-apoptotic signals if the cells cannot
adapt to aggregate-induced stress; interestingly, several molecules
and mechanisms were suggested to mediate the transition from an
adaptive stress response to apoptosis, including the CHOP
transcription factor, caspase activation, Ca
2+ release and mito-
chondrial signaling [7].
A recent study [65] investigated another Rh1 allele (ninaE
G69D)
which, although not found in RP patients, has been classified as
class II Rh mutation [33]. Overexpression (Rh1 promoter driven)
of ERAD members Hrd1 and EDEM2 partially rescued late-onset
PN degeneration and loss of mature Rh1 in ninaE
G69D flies.
Interestingly, reduced Hrd1 or EDEM2 function (by RNAi) also
rescued mature Rh1 levels, although its effect on PN degeneration
was not assessed. These observations might hint at different
mechanisms of dominance or different levels of UPR activation
among the different Rh1 alleles (see [7]). Another possibility is that
early clearance of the mutant Rh1 (via enhanced ERAD) might
have long-term protective effects [65]. Therefore, the manipula-
tion of ERAD activity for therapeutic purposes should take into
account the temporal profile of Rh aggregation and the relative
contribution of endogenous Rh to oligomeric species/aggregates
associated with each individual Rh dominant mutation.
Recent evidence suggests that VCP is also a mediator of
autophagy, the second major route for protein clearance in cells
[51–53]. Autophagy and the ubiquitin-proteasome system (UPS)
appear to be coordinated processes, with the autophagy being
upregulated upon proteasome impairment [66]. The enhanced
autophagy that follows UPS inactivation requires the cytoplasmic
histone deacetylase HDAC6 [67] and interestingly, HDAC6
interacts with VCP to determine the fate of ubiquitinated
misfolded proteins [68]. Inhibition of VCP might decrease
autophagic degradation of Rh1 and confer neuroprotection in
our Rh1
P37H flies; however, proteasomal inhibition (that should
cause enhanced autophagy) was neuroprotective for the Rh1
P37H
retina (Figure 6) and we detected no significant impairment of
proteasomal function in Rh1
P37H flies (A.Gr. and M.U., unpub-
lished observations). These conflicting scenarios and the recent
failure of autophagy induction to suppress Rh1
RH27-mediated
retinal pathology in Drosophila [69] argue for additional studies to
address the relevance of autophagy-promoting VCP activity to
retinal degeneration caused by misfolded Rh.
Promoting Neuroprotection in the Rh
P23H Retina
Inhibition of VCP activity or reduced dosage of the endogenous
Rh1 conferred neuroprotection for Rh1
P37H-expressing PNs, and
were associated with increased UPR activation, via the Ire1/
Xbp1-mediated Hsc3/BiP production (Figure 2, Figure 4, and
Figure 5). Since VCP/ERAD/proteasome inactivation might
upregulate other pro-survival pathways, it remains to be
determined whether Ire1/Xbp1/Hsc3 activation mediates neuro-
protection in the Rh1
P37H retina. It is interesting to note that Rh1
accumulation within the ER was recently shown to induce a
moderate activation of the Ire1/Xbp1 pathway which induced
long-term pro-survival effects, via inhibition of caspase activation
and induction of an antioxidant response [20]. Another study
found that subretinal delivery of adeno-associated viruses express-
ing BiP prevented Rh
P23H-mediated retinal degeneration in rats by
suppressing the production of the pro-apoptotic protein CHOP
[70]. However, it should be noted that, besides activating Ire1/
Xbp1, UPR can also promote apoptosis via two independent
pathways [18]. Thus, a better understanding of the differential
regulation of UPR pathways during ER stress might provide
further clues about the regulation of cellular survival versus
apoptosis in PNs expressing misfolded Rh
P23H.
Is partial VCP inactivation able to protect against retinal
degeneration in Rh
P23H-linked RP? We found that VCP inactiva-
tion prevents neurodegeneration in Rh1
P37H flies and VCP
inhibition is also sufficient to rescue mutant CFTR from
degradation and to partially restore CFTR function in a cellular
model of cystic fibrosis [28]. However, mutations that impair VCP
function are associated with inclusion body myopathy associated
with Paget disease of bone and frontotemporal dementia
(IBMPFD) [71,72]. It remains therefore to be determined whether
changes in VCP function suppress some pathologies and enhance
others. One interesting experiment is the evaluation of the effect of
VCP and proteasome inactivation in the Rh
P23H mouse retina,
preferably using local delivery. An improved understanding of the
molecular machinery linking Rh quality control and the networks
regulating PN maintenance might uncover cellular targets acting
specifically in the retina, thus facilitating the therapeutic
approaches for RP.
Materials and Methods
Drosophila Stocks
Drosophila lines p(w
+ Rh1-Rh1
WT), p(w
+ Rh1-Rh1
P37H), p(w
+ Rh1-
Rh1
P37H-hsv) and p(w+ Rh1-Gal4) lines referred to as Rh1
WT;Rh1
+/+,
Rh1
P37H;Rh1
+/+, Rh1
P37H-hsv;Rh1
+/+ and Rh1-Gal4 were previously
described [11]. ninaE
D1 (ninaE
S137F) and p(ry
+ rh1-Rh1
WT-hsv)
referred to as Rh1
WT-hsv;Rh1
+/+ were a gift kind from J.E.
O’Tousa. ter94
26-8 hypomorphic allele, referred to as VCP
26-8,
was kindly provided by E. Goldstein. UAS-xbp1-EGFP was a
generous gift from H.D. Ryoo. Actin-Gal4, ninaE-null I17 (referred
to as Rh1
2), ter94
k15502 (referred to as VCP
k15502, strong LOF allele)
and w
1118 flies were from the Bloomington stock center. Flies were
raised on standard cornmeal agar medium, under moderate
continuous illumination at 25uC. Moderate illumination was
obtained by using photosynthetic fluorescent tubes (in total
170 cd/m
2). Fly progeny having same eye pigmentation was used
during the study.
Western Blotting
WB was performed as described [15,73,74]. Briefly, 30 fly heads
were homogenized in 60 ml of RIPA modified buffer (20 mM Tris-
HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
0.1% SDS and 0.5% sodium deoxycholate) supplemented with
protease inhibitors (Roche) and phosphatase inhibitors (Sigma-
Aldrich). Lysates were centrifuged at 16.000 g for 15 minutes at
4uC. For detergent-insoluble factions, pellets were solubilised in
50 ml solution containing 10 mM Tris-HCl pH 7.5, 1% SDS and
protease inhibitor cocktail for 8 minutes at room temperature.
100 ml of RIPA modified buffer containing protease inhibitors was
added, and the pellets were then sonicated six times (10 seconds
each) at 4uC. Following sonication, the fractions were incubated
30 minutes at 4uC. Detergent-insoluble fractions were then
centrifuged at 100 g for 10 minutes at 4uC and tissue debris were
discarded. For Western Blotting, fractions were normalized for
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volume of 26 Laemmli sample buffer was added to fractions
separated by 10% SDS-PAGE for detergent-soluble and by 8%
SDS-PAGE for detergent-insoluble fractions and electroblotted
onto PVDF membranes (GE Healthcare). Immunodetection was
performed according to standard techniques using the following
primary antibodies: anti-Rh1 (rabbit polyclonal, 1/5000, gift from
D.F. Ready) for detecting Rh1 in detergent-insoluble fractions,
4C5 (mouse monoclonal, 1/5000, DSHB) that detects Rh1 in
detergent-soluble fractions, anti-ter94/VCP (rat, 1/5000, gift from
D. McKearin), anti-hsv (rabbit polyclonal, 1/8000, Sigma), anti-
Hsc3 (guinea pig, 1/2000, gift from H.D. Ryoo), anti-Ubiquitin
(mouse monoclonal, 1/300, Invitrogen), anti-TRP (1/10000, gift
from A. Huber) and anti-b-Tubulin (mouse monoclonal, 1/4000,
Chemicon). Secondary antibodies were horseradish peroxidase-
coupled (1/8000, Jackson Immunoresearch). Quantification of
band intensity after ECL detection was performed using Image
Quant TL software.
Histology and Immunohistochemistry
Heads were dissected and fixed for 24 h in 2.5% glutaralde-
hyde, phosphate buffered saline (PBS, pH 7.4) and post-fixed in
1% osmium tetroxide in PBS. After a series of ethanol and
propylene oxide dehydration, heads were embedded in epoxy
resin (Sigma-Aldrich). For toluidine blue staining, semithin (2 mm)
sections were stained with 1% toluidine blue [75]. To determine
the average number of photoreceptors/ommatidium (P/O), at
least l50 ommatidia were scored per animal from at least 4 animals
per genotype.
Immunohistochemistry was performed as described [11,37],
heads were dissected and fixed for 15 minutes in 4% formalde-
hyde, incubated in 10% sucrose during 2 hours and then in 25%
sucrose overnight at 4uC, then embedded in cryomedium. 16 mm-
thick cryostat sections were fixed for 15 minutes in 4%
formaldehyde, permeated with 0.3% Triton-X 100 in PBS (PBST)
during 30 minutes and blocked during 1h with 5% normal goat
serum in PBST. To detect non-conventional xbp1 mRNA splicing
of the xbp1-EGFP construct, we used an anti-GFP antibody (rabbit
polyclonal, 1/400, Molecular Probes) diluted in blocking solution.
After overnight incubation with primary antibody, an alkaline
phosphatase-linked anti-rabbit secondary antibody (1/200, Sigma-
Aldrich) was added for 2 hours at room temperature. Sections
were washed with alkaline phosphatase buffer (100 mM NaCl,
50 mM MgCl2, 100 mM Tris-HCl pH 9.5, 0.1% Tween 20).
Then, sections were incubated with BCIP/NBT substrate (Sigma-
Aldrich) during 30 minutes, washed in water, air-dried and
mounted in a non-aqueous mounting medium (Clarion, Sigma-
Aldrich).
Pharmacological Treatments
Flies were treated with EerI (ChemBridge Corporation, catalog
nu 5138427) or MG132 (Sigma-Aldrich) inhibitors dissolved in
their food. We used 2 doses of EerI (1 mM and 10 mM) and 2
doses of MG132 (5 mM and 50 mM). These compounds were first
dissolved in DMSO and the solution was then added to cooled
cornmeal agar fly food. The food was then dispensed into empty
vials and allowed to solidify. It was kept at 4uC in the dark for
maximum 3 days. The above-mentioned concentrations corre-
spond to the final concentrations in fly food. Flies were transferred
in vials containing this modified food right after birth, were reared
as described above and transferred to fresh vials every day. The
control food contained all the ingredients (including DMSO)
except the active compound. After 30 days of light exposure, flies
fed on control food (2% DMSO) and on drug food (EerI or
MG132 in 2% DMSO) were sacrificed and their retinal integrity
was assessed histologically.
Behavioral Assays
Fast phototaxis was performed as previously described [11].
Briefly, 20 flies were placed in tube 1 of a countercurrent
apparatus with six tubes and gently tapped to the bottom of the
tube. The apparatus was placed horizontally, the light source was
switched on and the flies were allowed to walk toward the light
during 30 seconds. The flies that moved toward the light were
shifted to the second tube and this procedure was repeated five
times. At the end of the test, the number of flies was counted in
each of the six tubes. Between 277–451 flies were scored per
genotype, in 3 independent experiments. The phototactic score
(PS) quantifies the visual activity following a weighted equation
(SiNi)/SNi, where N is the number of flies in the i
th tube.
Geotaxis was used to assess motor performance in flies
chronically exposed to light. About 20 flies/tube were gently
tapped to the bottom of the tube and then allowed to climb during
20 seconds. We then scored the number of flies that climbed 4 cm
or above. Each tube was tested twice. The results represent the%
of flies that reached 4 cm or above after 20 seconds.
Electroretinogram
Electroretinogram analysis was performed as previously de-
scribed [11]. A tungsten electrode was introduced in the back of
the fly head and a glass electrode filled with 3M KCl was
introduced through the cornea. Flashes were delivered using a
white LED (Nichia, NSPW510BS, emitting from 425 to 750 nm
with two peaks at 460 and 560 nm) with a 45u viewing angle,
placed at 1.5 cm from the fly eye and controlled via an Analog
Out port of a Digidata 1322A (Molecular Devices, USA). After
5 minutes of dark-adaptation, six 1 second light pulses were used
to stimulate the eye and their responses averaged. The light
intensity reaching the eye (,300 mW/cm
2) was chosen as the
minimal intensity that consistently produced maximal ERG
plateaus.
Supporting Information
Figure S1 Rh1
P37H-expressing flies show no retinal degeneration
when reared in the dark or after a short exposure to light. (A–D)
Photomicrographs of toluidine blue-stained semithin adult eye
sections of Rh1
WT;Rh1
+/+(A,C) and Rh1
P37H;Rh1
+/+ flies (B,D)
reared in the light until postnatal day 1 (P1) (A,B) or reared in the
dark until P30 (C,D). No loss of photoreceptor neurons is observed
under these conditions. Scale bar is 50 mm.
Found at: doi:10.1371/journal.pgen.1001075.s001 (2.17 MB TIF)
Figure S2 Rh1 levels in Rh1
WT-expressing and Rh1-Gal4 flies
exposed to light. (A,B) Immunoblots revealing the abundance of
total (endogenous and ectopic) Rh1 in detergent-soluble (A) or
insoluble (B) fractions obtained from retina lysates of Rh1
WT;Rh1
+/+
orRh1-Gal4fliesexposedtolight forthe indicateddurations.A short
exposure of the Rh1 WB is shown (A) in order to better visualize the
differences in Rh1 levels between Rh1
WT;Rh1
+/+ and Rh1-Gal4 flies.
b-Tubulin (b-Tub) served as loading control.
Found at: doi:10.1371/journal.pgen.1001075.s002 (0.68 MB TIF)
Figure S3 Rh1
WT and Rh1
P37H transgene expression and light-
induced Rh1
P37H maturation defects. (A–C) Immunoblots reveal-
ing the abundance of total Rh1 (endogenous and ectopic, Rh1
antibody) (A,B) and ectopic Rh1 (hsv antibody) (C) in detergent-
soluble fractions obtained from retinas of Rh1-Gal4, Rh1
WT;Rh1
+/+
or Rh1
P37H;Rh1
+/+ flies reared at light (A–C) or in the dark (C) for
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P37H shows maturation defects in the
presence of light (C). (D) Immunoblot showing the levels of total
Rh1 (endogenous and ectopic, Rh1 antibody) in detergent-soluble
fractions obtained from retinas of flies of indicated genotypes
reared at light for 10 days. Complete absence of endogenous Rh1
leads to high expression levels of the mutant Rh1
P37H transgene
(see lanes 3 and 4 in Rh1 WB), and under these conditions, the
levels of mature Rh1
P37H are significantly higher. Please note that
(unlike in C, lanes 2 and 6) only ectopic Rh1
P37H is present in D
(lanes 3 and 4) and that the Rh1 signal therefore indicates the
amount of mature Rh1
P37H in these retinas. b-Tubulin (b-Tub)
served as loading control.
Found at: doi:10.1371/journal.pgen.1001075.s003 (1.18 MB TIF)
Figure S4 Loss of Rh1
P37H in Rh1
P37H-expressing flies exposed
to light. (A,B) Immunoblots revealing the abundance of total
(endogenous and ectopic, Rh1 antibody) and ectopic (hsv
antibody) Rh1 in detergent-soluble (A) or insoluble (B) fractions
obtained from retinas of Rh1
WT;Rh1
+/+ or Rh1
P37H;Rh1
+/+ flies
exposed to light for the indicated durations. Aggregates were
independently labeled with an Ubiquitin-specific antibody (B).
Found at: doi:10.1371/journal.pgen.1001075.s004 (1.11 MB TIF)
Figure S5 Rescue of retinal degeneration in Rh1
P37H-expressing
flies lacking endogenous Rh1. Immunoblot showing the levels of
total Rh1 (Rh1 antibody) in detergent-soluble fractions obtained
from retinas of flies of indicated genotypes reared at light for 25
days. Rh1
P37H transgene expression in a Rh1 null background
(lanes 3 and 4) suppresses retinal degeneration and prevents the
loss of Rh1 seen in Rh1
P37H;Rh1
+/+ flies (lane 2). b-Tubulin (b-
Tub) served as loading control.
Found at: doi:10.1371/journal.pgen.1001075.s005 (0.27 MB TIF)
Figure S6 VCP inactivation increases Rh1 aggregate load and
restores the levels of mature Rh1 in Rh1
P37H-expressing flies. (A)
Flies carrying the VCP hypomorphic allele VCP
26-8 have reduced
levels of VCP. Adult WT and VCP
26-8/+ (genotype: VCP
26-8/+;
Rh1
+/+) flies were tested for VCP expression levels using a VCP-
specific antibody.VCP levels are significantly reduced inVCP
26-8/+
flies, as compared to WT flies. (B,C) Immunoblots showing levels of
total (endogenous and ectopic, Rh1 antibody; B) and ectopic (hsv
antibody; C) Rh1 aggregates in flies of indicated genotypes after 20
days of light exposure (dle). An Ubiquitin-specific antibody was
used to independently label aggregates. The amount of aggregated
(endogenous and ectopic) Rh1 increases in Rh1
P37H;VCP
26-8/+;
Rh1
+/+ flies compared to control and mutant Rh1
P37H;Rh1
+/+ flies
(B). Aggregates containing the ectopic Rh1
P37H are also rescued
from degradation after partial VCP inactivation (C). (D,E)
Immunoblots revealing the levels of total (endogenous and ectopic,
Rh1 antibody; D) and ectopic (hsv antibody; E) mature Rh1 in flies
of indicated genotypes after 20 dle. There is loss of mature Rh1 in
Rh1
P37H;Rh1
+/+ flies, which is rescued when reducing VCP function
(D). Loss of ectopic mature Rh1
P37H in Rh1
P37H;Rh1
+/+ flies is also
rescued in Rh1
P37H;VCP
26-8/+;Rh1
+/+ flies (E). Ectopic Rh1 was
hsv-tagged in Rh1
WT;Rh1
+/+ or Rh1
P37H;Rh1
+/+ flies; no hsv signal
was detected in Rh1-Gal4 flies which lacked hsv-tagged Rh1 (E).
Please note that 10-fold less protein was loaded for Rh1
WT;Rh1
+/+
flies (E). (F) Immunoblot revealing the levels of Hsc3 in
Rh1
WT;Rh1
+/+ and Rh1
P37H;Rh1
+/+ retinas, exposed to light for
increasing durations. A 1.5-fold increase of Hsc3 levels is seen in
Rh1
P37H;Rh1
+/+ versus Rh1
WT;Rh1
+/+ retinas starting at day 1. b-
Tubulin (b-Tub) served as loading control. (G) Quantification of
Hsc3 expression levels. The results are expressed as mean
percentage compared to Hsc3 levels in Rh1
WT;Rh1
+/+ retinas at
day 1 (100%) and were averaged from three independent
experiments (** p,0.01 t-test).
Found at: doi:10.1371/journal.pgen.1001075.s006 (0.70 MB TIF)
Figure S7 The proteasome inhibitor MG132 potently suppress-
es proteasome activity in Drosophila. Head fly lysates were assayed
for the proteasome activity in the absence (control, 0.5% DMSO)
or presence of the proteasome inhibitor MG132 (50 mM MG132
in 0.5% DMSO). The results are shown as mean percentage
compared to proteasome activity levels in fly lysates treated with
DMSO (set as 100%) and were averaged from three independent
experiments (*** p,0.001 t-test).
Found at: doi:10.1371/journal.pgen.1001075.s007 (0.05 MB TIF)
Figure S8 Retinal pathology in ninaE
D1 and Rh1
P37H flies is
rescued by VCP or Rh1 inactivation. (A–C) Photomicrographs of
toluidine blue-stained semithin eye sections of WT (A), ninaE
D1/+
(B), VCP
26-8/+;ninaE
D1/+ (C) flies after 30 days of light exposure
(dle). Scale bar is 50 mm. (D) Quantification of average number of
photoreceptors/ommatidium (P/O) (n.6 animals/group,
** p,0.01 and *** p,0.001 t-test). Decreasing VCP function
suppresses retinal degeneration caused by ninaE
D1. (E) Phototaxis
histogram after 12 dle revealing the light response of flies of
indicated genotypes. ninaE
D1/+ flies show visual impairment
relative to WT flies, while VCP
26-8/+;ninaE
D1/+ flies display rescue
of visual acuity. Between 250–300 flies were scored/genotype. (F)
Phototactic score (PS) of WT, ninaE
D1/+ and VCP
26-8/+;ninaE
D1/+
flies after 12 dle (n=250–300 flies/group, ** p,0.01 and
*** p,0.001 t-test). (G) Geotactic score of WT, ninaE
D1/+ and
VCP
26-8/+;ninaE
D1/+ flies after 12 dle. Flies from all genotypes
display similar geotactic scores. (H) Phototaxis histogram after 20
dle revealing the light response of flies of indicated genotypes.
While Rh1
P37H;Rh1
+/+ flies show visual impairment,
Rh1
P37H;VCP
k15502/+;Rh1
+/+ flies have an improved visual acuity.
Between 150–200 flies were scored/genotype. (I) PS of
Rh1
P37H;Rh1
+/+ and Rh1
P37H;VCP
k15502/+;Rh1
+/+ flies after 20 dle
(n=150–200 flies/group, *** p,0.001 t-test). (J) Geotactic score of
Rh1
P37H;Rh1
+/+ and Rh1
P37H;VCP
k15502/+;Rh1
+/+ flies after 20 dle.
Flies from both genotypes show similar geotactic scores. (K)
Phototaxis histogram after 20 dle revealing the light response of
flies of indicated genotypes. Rh1
P37H;Rh1
+/+ flies display visual
impairment compared to Rh1
WT;Rh1
+/+ flies, while Rh1
P37H;Rh1
+/
2 flies have an improved visual acuity. Between 200–230 flies were
scored/genotype. (L) PS of Rh1
WT;Rh1
+/+, Rh1
P37H;Rh1
+/+ and
Rh1
P37H;Rh1
+/2 flies after 20 dle (n=200–230 flies/group,
*p ,0.05; ** p,0.01 t-test). (M) Geotactic score of Rh1
WT;
Rh1
+/+; Rh1
P37H;Rh1
+/+ and Rh1
P37H;Rh1
+/2 flies after 20 dle.
Flies from all genotypes show similar geotactic scores.
Found at: doi:10.1371/journal.pgen.1001075.s008 (1.16 MB TIF)
Text S1 Supplementary Materials and Methods. Measurement
of proteasome activity from fly head extracts.
Found at: doi:10.1371/journal.pgen.1001075.s009 (0.03 MB
DOC)
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